Tirzepatide vs Semaglutide: Complete Comparison Guide

Comprehensive comparison of tirzepatide vs semaglutide covering mechanisms, weight loss results, dosing schedules, side effects, and guidance on choosing between them.

Understanding GLP-1 Medications

Tirzepatide and semaglutide are both GLP-1 receptor agonists used for weight management and type 2 diabetes. While they share similarities, there are key differences that may make one more suitable than the other for different individuals.

Mechanism of Action

Semaglutide (Ozempic/Wegovy)

Semaglutide is a single-action GLP-1 receptor agonist. It mimics the GLP-1 hormone, which:

  • Slows gastric emptying
  • Increases feelings of fullness
  • Reduces appetite
  • Improves blood sugar control

Tirzepatide (Mounjaro/Zepbound)

Tirzepatide is a dual-action GIP/GLP-1 receptor agonist. It activates both:

  • GLP-1 receptors (same as semaglutide)
  • GIP (glucose-dependent insulinotropic polypeptide) receptors

This dual mechanism may provide enhanced metabolic benefits.

Weight Loss Comparison

MedicationAverage Weight LossStudy Duration
Semaglutide 2.4mg~15-17%68 weeks
Tirzepatide 15mg~20-22%72 weeks

Clinical studies suggest tirzepatide may produce greater weight loss on average, though individual results vary significantly.

Dosing Schedules

Semaglutide Titration

  • Week 1-4: 0.25mg weekly
  • Week 5-8: 0.5mg weekly
  • Week 9-12: 1.0mg weekly
  • Week 13-16: 1.7mg weekly
  • Week 17+: 2.4mg weekly (maintenance)

Tirzepatide Titration

  • Week 1-4: 2.5mg weekly
  • Week 5-8: 5mg weekly
  • Week 9-12: 7.5mg weekly
  • Week 13-16: 10mg weekly
  • Week 17-20: 12.5mg weekly
  • Week 21+: 15mg weekly (maintenance)

Side Effects Comparison

Both medications share similar side effects, primarily gastrointestinal:

  • Nausea (most common)
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal pain

Side effects are typically most pronounced during dose increases and often diminish over time.

Key Differences Summary

FactorSemaglutideTirzepatide
MechanismGLP-1 onlyGLP-1 + GIP dual
Max dose2.4mg/week15mg/week
Avg weight loss15-17%20-22%
FDA approved20212023

Which Should You Choose?

The choice between tirzepatide and semaglutide should be made with a healthcare provider based on:

  • Your specific health conditions
  • Previous medication responses
  • Insurance coverage and cost considerations
  • Individual weight loss goals

Use our Peptide Calculator to help with dosing calculations for either medication.